Latest news
25 items- 13D/GSEC Form SC 13D filed by Mountain Crest Acquisition Corp. IISC 13D - Better Therapeutics, Inc. (0001832415) (Subject)
- 13D/GSEC Form SC 13D filed by Mountain Crest Acquisition Corp. IISC 13D - Better Therapeutics, Inc. (0001832415) (Subject)
- 13D/GSEC Form SC 13G filed by Mountain Crest Acquisition Corp. IISC 13G - Better Therapeutics, Inc. (0001832415) (Subject)
- SECMountain Crest Acquisition Corp. II filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell Company Status8-K - Better Therapeutics, Inc. (0001832415) (Filer)
- INSIDERSEC Form 3: New insider Heinen Mark claimed ownership of 6,667 shares3 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 4: Perry David P bought $2,512,432 worth of shares (251,536 units at $9.99) and was granted 10,578,501 shares4 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 3: New insider Parker Geoffrey M. claimed ownership of 33,333 shares3 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 4: Heinen Mark was granted 6,667 shares, increasing direct ownership by 25% to 33,333 units4 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 4: Parker Geoffrey M. was granted 33,333 shares4 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 4: Liu Suying acquired 1,402,500 shares4 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 4 filed by Lavizzo-Mourey Risa J4 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 3: New insider Perry David P claimed ownership of 10,830,037 shares3 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 3: New insider Wynholds Kristin claimed ownership of 90,015 shares3 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 3 filed by new insider Zamirowski Justin3 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 4: Armanino Andrew J. was granted 61,662 shares4 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 3: New insider Armanino Andrew J. claimed ownership of 61,662 shares3 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 3: New insider Carmona Richard H claimed ownership of 153,619 shares3 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 3: New insider Appelbaum Kevin J claimed ownership of 2,406,719 shares3 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 4: Carmona Richard H was granted 153,619 shares4 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 3: New insider Berman Mark A. claimed ownership of 231,939 shares3 - Better Therapeutics, Inc. (0001832415) (Issuer)
- INSIDERSEC Form 3 filed by new insider Lavizzo-Mourey Risa J3 - Better Therapeutics, Inc. (0001832415) (Issuer)
- 13D/GSEC Form SC 13G/A filed by Mountain Crest Acquisition Corp. II (Amendment)SC 13G/A - Better Therapeutics, Inc. (0001832415) (Subject)
- PRBetter Therapeutics Closes Business Combination and Debuts on NasdaqTrading to commence on Nasdaq on Oct. 29, 2021, under the ticker symbol BTTX Better Therapeutics, Inc., a prescription digital therapeutics (PDT) company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the completion of its business combination with Mountain Crest Acquisition Corp II (NASDAQ:MCAD, "Mountain Crest II"))), a publicly traded special purpose acquisition corporation or SPAC. The resulting combined company will commence trading its shares on Nasdaq under the ticker symbol "BTTX" on October 29, 2021. The shareholders of Mountain Crest Acquisition Corp II approved the transaction at a special meeting held on October
- SECSEC Form 25-NSE filed by Mountain Crest Acquisition Corp. II25-NSE - Mountain Crest Acquisition Corp II (0001832415) (Subject)
- SECSEC Form 425 filed by Mountain Crest Acquisition Corp. II425 - Mountain Crest Acquisition Corp II (0001832415) (Subject)
MCAD FAQ
5 questionsWhat does Mountain Crest Acquisition Corp. II do?
Mountain Crest Acquisition Corp. II. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.Where does MCAD stock trade?
Mountain Crest Acquisition Corp. II (MCAD) is listed on NASDAQ.What sector and industry is MCAD in?
Mountain Crest Acquisition Corp. II operates in the Finance sector.What are analysts saying about MCAD?
Mountain Crest Acquisition Corp. II has had 1 recent analyst action on file. The most recent action was from Lake Street: Buy with a $1900.00 price target on 2021-07-29. Recent price targets cluster around $1900.00.How can I track MCAD on Quantisnow?
Quantisnow aggregates Mountain Crest Acquisition Corp. II's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MCAD to receive live email and push alerts on every new disclosure.